On November 15, 2021 Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, reported that company management will participate in the following upcoming investor conferences (Press release, Asher Biotherapeutics, NOV 15, 2021, View Source [SID1234595640]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 33rd Annual Virtual Healthcare Conference
Craig Gibbs, Ph.D., Chief Executive Officer, will pre-record a corporate presentation, which will become available to registered conference attendees on Monday, November 22, 2021 at 10:00 a.m. ET (7:00 a.m. PT). Company management will be participating in 1×1 meetings on Monday, November 29, 2021.

Evercore ISI 4th Annual HealthconX Conference
Craig Gibbs, Ph.D., will participate in a fireside chat on Wednesday, December 1, 2021 at 10:05 a.m. ET (7:05 a.m. ET). Company management will be participating in 1×1 meetings on Wednesday, December 1, 2021.